BHVN

Neutral

Biohaven (BHVN) Valuation Check After Q1 Results And New Shelf Registration

Biohaven (BHVN) is under scrutiny after its Q1 results and a new shelf registration. Despite a reduced net loss, its share price has fallen significan...

Simply Wall Street Yesterday 0

Neutral

H.C. Wainwright reiterates Biohaven stock rating ahead of trial

H.C. Wainwright has reiterated a Neutral rating and $10.00 price target for Biohaven Pharma (BHVN) due to uncertainty surrounding its pipeline, as the...

Investing.com Yesterday 0